Venus Concept

Venus Concept FCF Yield

Delisted

The Free Cash Flow Yield of Venus Concept (VERO) as of Oct 24, 2026 is -927.48 %. In the previous year, Free Cash Flow Yield was -1,075.53 % — a change of -13.76% (higher).

FCF Yield

-927.48 %

YoY

-13.76%

Last updated:

Free Cash Flow Yield of Venus Concept is 2024 -927.48 % . Free Cash Flow Yield of Venus Concept was 2023 -1,075.53 % . It decreases by -13.76% higher compared to the previous year.

The Venus Concept FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2017
-1,615.16 USD
Jan 1, 2018
-2,462.32 USD
Jan 1, 2019
-3,375.21 USD
Jan 1, 2020
-2,398.99 USD
Jan 1, 2021
-1,681.30 USD
Jan 1, 2022
-2,264.29 USD
Jan 1, 2023
-1,075.53 USD
Jan 1, 2024
-927.48 USD
The Venus Concept FCF Yield history
YEARFCF YieldYoY
-927.48 %-13.76%
-1,075.53 %-52.50%
-2,264.29 %+34.67%
-1,681.30 %-29.92%
-2,398.99 %-28.92%
-3,375.21 %+37.07%
-2,462.32 %+52.45%
-1,615.16 %+12.39%
-1,437.10 %-29.45%
-2,037.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Venus Concept Stock analysis

What does Venus Concept do? Venus Concept, Inc. generates revenue through its portfolio of medical aesthetic and hair restoration technologies, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Skin, and Venus Bliss. The company sells these products to clinics and medical practices globally, operating in over 60 countries and 29 direct markets. Its hair restoration division features NeoGraft, an automated system for follicular unit extraction (FUE) procedures. Venus Viva combines NanoFractional Radio Frequency (RF) and SmartScan technology for facial, neck, and body treatments, while Venus Fiore targets vaginal health restoration with three specialized applicators. The company’s revenue streams include direct sales of devices and related practice enhancement services. Products like Venus Legacy and Venus Freeze Plus are marketed for non-invasive aesthetic procedures, while NeoGraft serves the hair restoration segment. Venus Fiore focuses on internal vaginal health, labia tightening, and mons pubis reduction, addressing niche medical needs. All offerings are distributed through the company’s global network, leveraging its presence in 29 direct markets. Venus Concept’s business model centers on selling minimally invasive and non-invasive medical aesthetic technologies to healthcare providers. The company’s product range spans multiple applications, from facial rejuvenation to hair restoration and intimate health. By maintaining a diverse portfolio under its branded products, Venus Concept ensures steady demand across various medical specialties and geographic regions. Venus Concept is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Venus Concept stock

Free Cash Flow Yield of Venus Concept is -927.48 % in 2024.

Free Cash Flow Yield of Venus Concept changed from -1,075.53 % to -927.48 %, representing a -13.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Venus Concept since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Venus Concept with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Venus Concept

All Key Metrics — Venus Concept